Literature DB >> 556919

Antiplatelet treatment of thrombotic thrombocytopenic purpura.

E L Amorosi, S Karpatkin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 556919     DOI: 10.7326/0003-4819-86-1-102

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

Review 1.  Disseminated intravascular coagulation: a review.

Authors:  P J Hamilton; A L Stalker; A S Douglas
Journal:  J Clin Pathol       Date:  1978-07       Impact factor: 3.411

2.  Thrombotic thrombocytopenic purpura (TTP) and splenectomy: a current appraisal.

Authors:  I M Rutkow
Journal:  Ann Surg       Date:  1978-11       Impact factor: 12.969

3.  Thrombotic thrombocytopenic purpura.

Authors:  R Kacich; C Linker
Journal:  West J Med       Date:  1982-06

4.  Platelet factor 4 and the response to plasma exchange in the treatment of thrombotic thrombocytopenic purpura.

Authors:  G Wiedemann; I Kantner; M Schenke; E Schulz; T Wagner
Journal:  Klin Wochenschr       Date:  1989-05-15

5.  Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura.

Authors:  S H Lee; J S Wainscoat; H Zeitlin; F G Bolton; H A Leaver; A Seawright; J M Preece
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-21

6.  Plasma exchange in thrombotic thrombocytopenic purpura.

Authors:  E B Toffelmire; W F Clark; P E Cordy; A L Linton; R C Lohmann
Journal:  Can Med Assoc J       Date:  1984-12-01       Impact factor: 8.262

7.  Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

Authors:  Cassiana E Bittencourt; Jennifer P Ha; Robert W Maitta
Journal:  PLoS One       Date:  2015-05-22       Impact factor: 3.240

8.  Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients.

Authors:  Mark Levandovsky; Danielle Harvey; Primo Lara; Ted Wun
Journal:  J Hematol Oncol       Date:  2008-12-01       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.